Company Overview of QuatRx Pharmaceuticals Company
QuatRx Pharmaceuticals Company, a biopharmaceutical company, engages in discovering, licensing, developing, and commercializing compounds in the areas of endocrine, metabolic, and cardiovascular therapeutics. Its products include Ophena for the treatment for vaginal atrophy, a common problem associated with estrogen deficiency in post-menopausal women; and Fispemifene for the treatment of testosterone deficiency and other conditions in men. The company’s products also include Sobetirome (QRX-431) for the treatment of dyslipidemia; and Asord (becocalcidiol) for the treatment of psoriasis. QuatRx Pharmaceuticals Company was founded in 2000 and is based in Ann Arbor, Michigan.
777 East Eisenhower Parkway
Ann Arbor, MI 48108
Founded in 2000
Key Executives for QuatRx Pharmaceuticals Company
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Sponsored Financial Commentaries
To contact QuatRx Pharmaceuticals Company, please visit www.quatrx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.